Cargando…

HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection

Circulating microparticles (MPs) are novel potential biomarkers in cancer patients. Their role in hepatocellular carcinoma (HCC) is under intensive investigation. In this study, we tested the hypothesis that MPs expressing the antigen HepPar1 are increased in the blood of subjects with HCC and may s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbate, Valeria, Marcantoni, Margherita, Giuliante, Felice, Vecchio, Fabio M., Gatto, Ilaria, Mele, Caterina, Saviano, Antonio, Arciuolo, Damiano, Gaetani, Eleonora, Ferrari, Maria C., Giarretta, Igor, Ardito, Francesco, Riccardi, Laura, Nicoletti, Alberto, Ponziani, Francesca R., Gasbarrini, Antonio, Pompili, Maurizio, Pola, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454955/ https://www.ncbi.nlm.nih.gov/pubmed/28498353 http://dx.doi.org/10.3390/ijms18051043

Ejemplares similares

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
por: Gaetani, Eleonora, et al.
Publicado: (2018)

Microparticles Carrying Sonic Hedgehog Are Increased in Humans with Peripheral Artery Disease
por: Giarretta, Igor, et al.
Publicado: (2018)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1
por: Radwan, Nehal A, et al.
Publicado: (2012)

Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group
por: Gaetani, Eleonora, et al.
Publicado: (2019)

The Hedgehog Signaling Pathway in Ischemic Tissues
por: Giarretta, Igor, et al.
Publicado: (2019)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Arteriovenous malformations: the newest Sonic hedgehog game in the postnatal brain
por: Giarretta, Igor, et al.
Publicado: (2020)

Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
por: Cerreto, Maria, et al.
Publicado: (2021)

Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)

Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
por: Maestri, Marta, et al.
Publicado: (2023)

Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
por: Faccia, Mariella, et al.
Publicado: (2019)

Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection
por: Ponziani, Francesca Romana, et al.
Publicado: (2021)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives
por: Paratore, Mattia, et al.
Publicado: (2021)

Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
por: Costante, Federico, et al.
Publicado: (2022)

Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis
por: Maccauro, Valeria, et al.
Publicado: (2023)

Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers
por: Cerrito, Lucia, et al.
Publicado: (2019)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
por: Rinninella, Emanuele, et al.
Publicado: (2020)

Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis
por: Rinninella, Emanuele, et al.
Publicado: (2020)

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

Intraoperative Ultrasound Staging for Colorectal Liver Metastases in the Era of Liver-Specific Magnetic Resonance Imaging: Is It Still Worthwhile?
por: Langella, Serena, et al.
Publicado: (2019)

Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites
por: Porfidia, Angelo, et al.
Publicado: (2019)

Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals
por: Cerrito, Lucia, et al.
Publicado: (2021)

Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection
por: De Maio, Flavio, et al.
Publicado: (2021)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

Pancytopenia in a Patient with Rendu-Osler-Weber Syndrome and Uncommon Vascular Abnormalities
por: Binello, Nicolò, et al.
Publicado: (2016)

Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
por: Pallozzi, Maria, et al.
Publicado: (2022)

Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

Viral Cirrhosis: an Overview of Haemostatic Alterations and Clinical Consequences
por: Ponziani, Francesca Romana, et al.
Publicado: (2009)

Intestinal Barrier in Human Health and Disease
por: Di Tommaso, Natalia, et al.
Publicado: (2021)

Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
por: Del Zompo, Fabio, et al.
Publicado: (2021)

Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors
por: Ainora, Maria Elena, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to Cancer
por: Manilla, Vittoria, et al.
Publicado: (2023)

Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
por: Pellegrino, Antonio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jagt5c40skcjiai308cm93kci4